Clinical Trial: Study on the Mechanism of Methionine Promoting Microvascular Invasion of Hepatocellular Carcinoma Cell Subpopulations (STMN1+/EZH2+) through Metabolic-Epigenetic Reprogramming (China)

Posted On: 2026-09-15

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Mechanism of Methionine Promoting Microvascular Invasion of Hepatocellular Carcinoma Cell Subpopulations (STMN1+/EZH2+) through Metabolic-Epigenetic Reprogramming'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132351

Registration Time: 2026/09/14

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341642

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the Mechanism of Methionine Promoting Microvascular Invasion of Hepatocellular Carcinoma Cell Subpopulations (STMN1+/EZH2+) through Metabolic-Epigenetic Reprogramming (China)